S&P 500
7,516.40
-0.04%
Dow Jones
52,439.50
-0.16%
Nasdaq 100
29,284.20
+0.08%
Russell 2000
2,951.26
-0.01%
FTSE 100
10,479.60
-0.30%
Nikkei 225
67,095.10
+0.05%

Personal Finance

NGEN logo NervGen Pharma Corp. : NGEN

NGEN

Stock Data

$1.93

Change up

$0.05 (2.66%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

NervGen Pharma Corp. (NGEN) is an innovative biotechnology company focused on addressing unmet medical needs in the field of neurodegenerative diseases through its proprietary platform, which leverages nerve regeneration technology. The company is committed to the research and development of novel therapeutics aimed at restoring nerve function and improving patient outcomes for conditions like multiple sclerosis and spinal cord injuries. With a strategic emphasis on advancing its clinical programs and enhancing its intellectual property portfolio, NervGen is well-positioned to capitalize on the growing demand for effective treatments in the neurology sector, fostering potential long-term growth and value creation for investors.

All NGEN Articles

2 Articles

No articles found for NGEN.